NEW YORK (GenomeWeb News) – Drug giant AstraZeneca has licensed GVK Biosciences’ Mechanism Based Toxicity Database, the Hyderabad, India-based firm announced today.

The database contains more than 13,000 drug and drug-like compounds, their routes of metabolism, toxic indications, and the numerical values of the measures of toxicity, according to GVK.

The license extends AstraZeneca’s existing license for all of GVK’s target and drug databases. Financial terms of the agreement were not disclosed.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.